Source:http://linkedlifedata.com/resource/pubmed/id/12133753
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-7-22
|
pubmed:abstractText |
We critically assessed studies on the clinical importance, diagnosis, incidence, and pathogenesis of peripheral vein infusion thrombophlebitis, including catheter-related and patient-related risk factors. We reviewed the evidence linking thrombosis, particularly prothrombotic states such as the inherited thrombophilic disorders, with peripheral vein infusion thrombophlebitis. Peripheral vein infusion thrombophlebitis occurs in 25% to 35% of hospitalized patients with peripheral intravenous catheters and has both patient-related implications (e.g., sepsis) and economic consequences (e.g., extra nursing time). Although duration of catheterization, catheter-related infection, and catheter material are important risk factors for peripheral vein infusion thrombophlebitis, patient-related risk factors are not well elucidated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9343
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12133753-Catheterization, Peripheral,
pubmed-meshheading:12133753-Female,
pubmed-meshheading:12133753-Humans,
pubmed-meshheading:12133753-Infusions, Intravenous,
pubmed-meshheading:12133753-Male,
pubmed-meshheading:12133753-Prevalence,
pubmed-meshheading:12133753-Primary Prevention,
pubmed-meshheading:12133753-Prognosis,
pubmed-meshheading:12133753-Risk Factors,
pubmed-meshheading:12133753-Severity of Illness Index,
pubmed-meshheading:12133753-Thrombophlebitis
|
pubmed:year |
2002
|
pubmed:articleTitle |
The epidemiology of peripheral vein infusion thrombophlebitis: a critical review.
|
pubmed:affiliation |
Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Canada. vicky.tagalakis@mail.mcgill.ca
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|